DIgestive COmplications in DIabetes - the DICODI population study
Moeen Ud-Din1, Bassam Karout2, Wiktoria M Torbé2
1Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Scandinavian Journal of Gastroenterology
|August 12, 2022
Summary
This study aims to develop a tool to help differentiate gastrointestinal symptoms in diabetes patients, addressing challenges posed by conditions like gastroparesis and celiac disease.
Area of Science:
- Gastroenterology
- Endocrinology
- Computational Biology
Background:
- Diabetes mellitus (type 1 and type 2) frequently causes gastrointestinal complications such as gastroparesis and gastroenteropathy.
- High prevalence of celiac disease and pancreatic exocrine insufficiency in diabetic patients leads to overlapping symptoms, complicating diagnosis.
- Differentiating these conditions from functional dyspepsia is a significant clinical challenge.
Purpose of the Study:
- To develop a clinical decision-support tool for differentiating underlying diseases in patients with diverse gastrointestinal symptoms.
- To identify risk factors and characterize gastrointestinal complications associated with diabetes.
- To explore biomarkers for autonomic neuropathy in diabetes.
Main Methods:
- An internet-based survey collected patient data and validated symptom scores for gastroparesis, gastroenteropathy, celiac disease, and pancreatic exocrine insufficiency.
- Logistic and multiple regression analyses identified risk factors and complications.
- Cluster analysis and machine learning were employed for symptom classification and diagnosis.
Main Results:
- Gastrointestinal symptoms are a significant concern for individuals with diabetes.
- The study aims to provide estimates of symptom prevalence and identify risk factors for gastrointestinal complications.
- Classifications of gastrointestinal complications will be developed for healthcare provider feedback.
Conclusions:
- The DICODI project, a web-based initiative, aims to detect gastrointestinal complications of diabetes in a real-world setting.
- This project will benefit individuals with diabetes, healthcare professionals, and society by improving diagnosis and management.
Keywords:
Celiac diseasecomplicationsgastroenteropathygastroparesismetabolic controlpancreatic exocrine insufficiencyMore Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
668
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
668
Diabetes Mellitus: Type 2 and Gestational
2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype
3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Dipeptidyl Peptidase 4 Inhibitors
239
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
239
Inflammatory Bowel Disease II: Crohn's Disease
364
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
364


